CIK: 1648920 - Address: Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane, CA 94005-1884
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret113514142823017
S%wins000000

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/5/18 16:05
3/1/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-6033.100-2-930D
3/5/18 16:05
3/1/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d53.02020D
2/5/18 16:05
2/1/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-23335.360-7-980D
2/5/18 16:05
2/1/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d203.02070D
1/4/18 16:05
1/2/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-24537.110-7-980D
1/4/18 16:05
1/2/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d203.02070D
12/28/17 17:45
12/26/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-2,91638.880-75-1000D
12/28/17 17:45
12/26/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d2273.020750D
9/11/17 17:17
9/7/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d913.020300D
9/11/17 17:17
9/7/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-67522.500-30-1000D
7/17/17 16:31
7/13/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.dm-32021.440-15-990D
7/17/17 16:31
7/13/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.dm453.020150D
7/6/17 17:01
7/3/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.dm-93920.850-45-1000D
7/6/17 17:01
7/3/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.dm1363.020450D
11/4/16 16:08
11/4/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-42417.602-24-1000D-72627-10-219402858
11/4/16 16:08
11/4/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d733.022240D-72627-10-219402858
10/7/16 16:05
10/5/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-42016.803-25-1000D-181857145783183521
10/7/16 16:05
10/5/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d763.023250D-181857145783183521
9/9/16 16:05
9/8/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaM.d913.023300D-27518371912133274541
9/9/16 16:05
9/8/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsRozenman Mary M.CAOSee RemaS.d-50416.803-30-1000D-27518371912133274541

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact